Prostate cancer (PCa) is the most common malignancy in western countries, representing the second leading cause of death. Androgen deprivation therapy (ADT) represents a good therapeutic tool for the treatment of PCa patients, but after an initial period of remission, the disease progresses towards an androgen-independent (AI) state. While in androgen-dependent (AD) stage the roles of androgens and their receptor (AR) are fully described, in AI, they are yet matter of research and discussion. Consolidate evidence demonstrate that, beside the well characterized genomic effects of AR, the non-classic ones contribute to PCa development and progression. In this chapter, we summarize the main non-classic androgen pathways and their involvement in the main phases of PCa. All these studies demonstrate that AR is a crucial factor both in pathogenesis, development and progression of PCa and its rapid effects are integrated with the genomic ones to mediate the complexity of the receptor signalling. In such a scenario taking into account, beside the classic mechanisms leading to AR activation, also the non-classic ones should be helpful to find new potential therapeutic targets for treatment of PCa.

Role of androgens and androgen receptor in prostate cancer: genomic and non-genomic actions / Marchiani S; Tamburrino L; Muratori M; Bonaccorsi L; Forti G; Baldi E. - STAMPA. - (2012), pp. 165-177. [10.1007/978-1-4614-1764-4_10]

Role of androgens and androgen receptor in prostate cancer: genomic and non-genomic actions

MARCHIANI, SARA;TAMBURRINO, LARA;MURATORI, MONICA;BONACCORSI, LORELLA;FORTI, GIANNI;BALDI, ELISABETTA
2012

Abstract

Prostate cancer (PCa) is the most common malignancy in western countries, representing the second leading cause of death. Androgen deprivation therapy (ADT) represents a good therapeutic tool for the treatment of PCa patients, but after an initial period of remission, the disease progresses towards an androgen-independent (AI) state. While in androgen-dependent (AD) stage the roles of androgens and their receptor (AR) are fully described, in AI, they are yet matter of research and discussion. Consolidate evidence demonstrate that, beside the well characterized genomic effects of AR, the non-classic ones contribute to PCa development and progression. In this chapter, we summarize the main non-classic androgen pathways and their involvement in the main phases of PCa. All these studies demonstrate that AR is a crucial factor both in pathogenesis, development and progression of PCa and its rapid effects are integrated with the genomic ones to mediate the complexity of the receptor signalling. In such a scenario taking into account, beside the classic mechanisms leading to AR activation, also the non-classic ones should be helpful to find new potential therapeutic targets for treatment of PCa.
2012
Advanced in rapid sex-steroid actions
165
177
Marchiani S; Tamburrino L; Muratori M; Bonaccorsi L; Forti G; Baldi E
File in questo prodotto:
File Dimensione Formato  
213580_1_En_10_Chapter_Author_Marchiani et al 2012_libro Castoria.pdf

Accesso chiuso

Tipologia: Versione finale referata (Postprint, Accepted manuscript)
Licenza: Tutti i diritti riservati
Dimensione 340.04 kB
Formato Adobe PDF
340.04 kB Adobe PDF   Richiedi una copia

I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificatore per citare o creare un link a questa risorsa: https://hdl.handle.net/2158/952331
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? 0
social impact